Bevacizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Bevacizumab is an anti-angiogenic drug that is used in the treatment of Metastatic Renal cell carcinoma, Metastatic breast cancer, Non-small cell lung cancer, and is also approved in the treatment Glioblastoma multiforme.[1]

[change] References

  1. http://www.medpagetoday.com/Neurology/BrainCancer/14078
Personal tools
Namespaces

Variants
Actions
Getting around
Print/export
Toolbox
In other languages